My lab focuses on engineering antibodies and immune cells to treat both solid tumors and liquid tumors in children.
Nai-Kong V. Cheung, MD, PhD
Enid A. Haupt Chair in Pediatric Oncology, Pediatrics
Professor
Research Focus
Physician-scientist Nai-Kong Cheung focuses on engineering antibodies and immune cells to treat both solid tumors and liquid tumors in children.Education
MD, PhD (Immunology), Harvard Medical School- Office Phone: 646-888-2313
- Lab Phone: 646-888-2320
Lab Members
Irene Cheung
Laboratory Member and Attending Clinical Immunologist
Madelyn Espinosa-Cotton
Research Fellow
Yi Feng
Senior Research Assistant
Hong-fen Guo
Research Assistant/Specialist
Sayed Shahabuddin (Shahab) Hoseini
Visiting Investigator
Tsung-Yi (Steven) Lin
Research Fellow
Aiza Malik
Research Technician
Jeong A Park
Research Fellow
Brian Santich
Research Fellow
Hoa Tran
Senior Research Assistant
Linlin Wang
Research Fellow
Mao (Sally) Wang
Research Fellow
Hong Xu
Senior Research Scientist
Publications
- Souweidane MM, Kramer K, Pandit-Taskar N, Zhou Z, Haque S, Zanzonico P, Carrasquillo JA, Lyashchenko SK, Thakur SB, Donzelli M, Turner RS, Lewis JS, Cheung NV, Larson SM, Dunkel IJ. Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial. Lancet Oncol. 2018 Jun 15. pii: S1470-2045(18)30322-X. doi: 10.1016/S1470-2045(18)30322-X.
- Kushner BH, Cheung IY, Modak S, Basu EM, Roberts SS, Cheung NK. Humanized 3F8 anti-GD2 monoclonal antibody dosing with granulocyte-macrophage colony-stimulating factor in patients with resistant neuroblastoma – A Phase 1 Clinical Trial. JAMA Oncol. 2018 September 20. doi:10.1001/jamaoncol.2018.4005
